Back to Search Start Over

Agios Announces Exclusive Worldwide License Agreement for Novel siRNA for the Potential Treatment of Polycythemia Vera

Source :
GlobeNewswire. August 3, 2023
Publication Year :
2023

Abstract

- Preclinical siRNA Targeting TMPRSS6 is a Potential Disease-Modifying Treatment for Polycythemia Vera - - Agreement Combines Agios' Scientific Expertise and Capabilities in Rare Hematologic Diseases with Alnylam's Industry-Leading siRNA [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
GlobeNewswire
Publication Type :
News
Accession number :
edsgcl.759426008